Altered expressions of SLPI and elafin have been identified in several carcinomas, and it appears that these aberrations may play a role in tumor formation, stimulation of metastatic potential, and development of malignant behavior in cancer cells, including breast cancer (BC) (12, 13). This evidence concerns the gene PI3 and breast cancer.